GLP-1s: A Quiet Drop-Off in Seniors - Top-Institutions - MDSpire

GLP-1s: A Quiet Drop-Off in Seniors

For many seniors, breakthrough weight-loss drugs deliver real benefits — until insurance denials, side effects, or muscle loss force them to quit.

  • By

  • Paula Span

  • January 6, 2026

  • 8 min

Share

Top Institutions in Family Medicine

Brief introduction explaining scope and methodology.

  • #1

    University of North Carolina School of Medicine
    University of North Carolina School of Medicine

    Chapel Hill, NC

    Key Differentiators

    • Endocrinology
    • Geriatrics
    • Obesity Medicine

  • #2

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Endocrinology
    • Health Services Research
    • Diabetes Care

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Obesity Medicine
    • Geriatrics

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Geriatrics
    • Obesity Research

  • #5

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Obesity Medicine

Original Source(s)

GLP-1s: A Quiet Drop-Off in Seniors

  • by Paula Span

  • January 6, 2026

Related Content

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

Postop Pain Differs by Vitamin D Status

Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.